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ALERT 
Airway pressure release ventilation (APRV) is not recommended in patients who 
require deep sedation. 
 
Ventilator failure or accidental disconnection can be catastrophic in patients 
undergoing neuromuscular blockade. Neuromuscular blockade can eliminate 
patient-ventilator asynchrony but not with a mode of ventilation requiring a 
spontaneously breathing patient. 
 
OVERVIEW  
APRV is a time-triggered, pressure-limited, time-cycled mode of ventilation that allows 
unrestricted spontaneous breathing throughout the entire ventilatory cycle. By allowing 
patients to spontaneously breathe during APRV, dependent lung regions may be 
preferentially recruited without the need to raise applied airway pressure. APRV is a lung-
protective strategy that helps to meet the goals of acute respiratory distress syndrome 
(ARDS) management and to diffuse pneumonia and atelectasis by maximizing alveolar 
recruitment while limiting the transalveolar pressure gradient and barotrauma. 
 
Conceptually, APRV applies a high continuous positive airway pressure (CPAP) (P high) 
identical to CPAP for a prolonged time (T high) to maintain adequate lung volume and 
promote alveolar recruitment. However, APRV adds a time-cycled release phase to a lower 
set CPAP (P low) for a short period of time (T low or release time) where most of the 
ventilation and carbon dioxide removal occurs. The goal is to maintain adequate 
oxygenation and ventilation without obvious lung distention during P high and to avoid lung 
derecruitment and intrinsic positive end-expiratory pressure (PEEP) during P low. 
 
Very few randomized controlled trials have been conducted to study APRV, and consensus 
among practitioners regarding initial APRV settings is limited.8 A time-controlled adaptive 
ventilation (TCAV) protocol should be used to establish appropriate APRV settings for each 
patient.6 
 
Given the current focus on the deleterious side effects of sedation medication and 
neuromuscular blockade, including delirium,5 APRV may begin to gain favor among 
practitioners, particularly when compared with high-frequency oscillatory ventilation 
(HFOV), which requires far deeper sedation levels and, in many cases, neuromuscular 
blockade.7 APRV has been shown to improve oxygenation, achieve a better ventilation–
perfusion match, and decrease dead space compared with conventional mechanical 
ventilation.4 
 
In APRV, the extended inspiratory time allows for an increase in the mean airway pressure 
(MAP) and improvement in oxygenation. Increasing the T high and P high increases MAP 
and lengthens the time for gas mixing, thereby optimizing the gas exchange surface area to 
promote oxygenation. 
 
When the measured arterial partial pressure of carbon dioxide (Paco2) becomes extreme, 
shortening T high increases the frequency with which carbon dioxide is released. Paco2 may 
increase if T high is increased, P high is decreased, or T low is decreased. 
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Patients who have obstructive lung disease with airflow obstruction and who require a 
prolonged expiratory time may not benefit from APRV because of patient-ventilator 
asynchrony (i.e., auto-PEEP and inverse inspiratory-to-expiratory [I:E] ratios). 
 
EDUCATION 
• Provide developmentally and culturally appropriate education based on the desire for 
knowledge, readiness to learn, and overall neurologic and psychosocial state.  
• Explain the need for ventilator changes to the patient and family. 
• Encourage questions and answer them as they arise. 
 
ASSESSMENT AND PREPARATION 
Assessment 
1. Perform hand hygiene before patient contact. 
2. Introduce yourself to the patient. 
3. Verify the correct patient using two identifiers. 
4. Observe the patient for signs of ARDS. 
 
a. Decreasing partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FIO2) 
ratio 
b. Increasing plateau pressures or peak airway pressures  
c. Bilateral infiltrates on a chest radiograph  
 
Preparation 
1. Before initiating mechanical ventilation, check the system microprocessor or ventilation 
system. Perform a short self-test as appropriate. 
 
a. Verify compliance of the heat-moisture exchanger (HME), humidifier, and filters (if 
needed). 
b. Document the completed ventilation system test. Include pass or fail, date, and initials 
or signature and credentials of the respiratory therapist (RT). 
 
2. Verify the authorized practitioner’s order for the initiation of mechanical ventilation. 
3. Use a TCAV protocol to guide ventilator settings and strategy when using APRV. 
 
PROCEDURE 
1. Perform hand hygiene and don gloves. 
2. Verify the correct patient using two identifiers. 
3. Explain the procedure to the patient and ensure that the patient agrees to treatment. 
4. Transition the patient to APRV from conventional ventilator settings. 
 
a. Set P high by using the measured plateau pressure of the volume-controlled mode or 
the set peak airway pressure of the pressure-controlled mode to obtain an expired 
minute ventilation that is several liters per minute less than when on a conventional 
mode of ventilation. Typically, the maximum goal for P high is 30 cm H2O.9 
 
Rationale: Limiting P high to 30 cm H2O may minimize ventilator-associated 
lung injury.9 
 
b. Set P low at 0 cm H2O.9 
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Rationale: P low of 0 produces minimal expiratory resistance and facilitates 
rapid pressure drops, thus accelerating unimpeded expiratory flow rates.3 
 
c. Set T high from 3 to 6 seconds and adjust according to the patient’s needs.9 
 
Rationale: T high of less than 3 seconds begins to negatively impact mean 
airway pressure and recruitment. Extending the T high period may be 
required to enhance carbon dioxide clearance.4 
 
d. Set T low from 0.5 to 0.8 seconds as determined by analysis of the expiratory gas flow 
curve.9 
 
Rationale: The goal is to terminate expiratory gas flow at about 75% to 50% 
of the peak expiratory flow rate to prevent the peak expiratory flow from 
returning to a zero baseline.3 T low should be short enough to prevent 
derecruitment and long enough to obtain a suitable tidal volume (VT).4 
 
5. Transition the patient who is newly intubated to APRV. 
 
a. Set P high to a maximum of 30 cm H2O (this higher transalveolar pressure recruits the 
lungs).9 
b. Set P low at 0 cm H2O.3 
c. Set T high from 3 to 6 seconds and adjust according to the patient’s needs.9 
d. Set T low from 0.5 to 0.8 seconds.9 
e. Set FIO2 for the desired PaO2 or arterial oxygen saturation (SaO2) level. 
 
6. Transition the patient to APRV from HFOV. 
 
a. Set P high with MAP on HFOV plus 2 to 4 cm H2O. 
b. Set P low at 0 cm H2O.9 
c. Set T high from 3 to 6 seconds and adjust according to the patient’s needs.9 
d. Set T low from 0.5 to 0.8 seconds (acute restrictive lung disease) or from 0.8 to 1.5 
seconds (acute obstructive lung disease).1 
 
7. Adjust settings based on the patient’s arterial blood gas (ABG) values, expiratory gas 
flow pattern, and clinical status. 
 
a. To decrease PaCO2: 
 
i. Decrease T high to no shorter than 3 seconds.3 
 
Rationale: A shorter T high means more releases per minute. 
 
ii. Increase P high to increase MAP and volume exchange in 2– to 3–cm H2O increments.9 
 
Monitor VT and peak inspiratory pressure, which is best below 30 cm 
H2O.3 
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iii. Check T low. If possible, increase T low to allow more time for exhalation. 
 
b. To increase PaCO2: 
 
i. Increase T high (fewer releases per minute) slowly. 
ii. Decrease P high to lower MAP. Monitor oxygenation and avoid derecruitment. Accepting 
hypercapnia may be better than reducing P high so much that oxygenation decreases. 
 
c. To increase PaO2: 
 
i. Increase FIO2. 
ii. Increase MAP by increasing P high in 2–cm H2O increments.2 
iii. Increase T high slowly (in 0.5-second increments).9 
iv. Use recruitment maneuvers. 
v. Consider shortening T low in 0.1-second increments (this may reduce VT and affect 
PaCO2).2 
 
8. Evaluate the patient’s scenario and follow these steps for weaning. 
 
a. Wean Fio2 to 40% first to rule out refractory hypoxemia. 
b. Reduce the level of P high (“drop”) and reduce the number of releases by increasing the 
T high (“stretch”) until the mode is converted to a CPAP of 15 cm H2O.2 
 
Rationale: The primary method to wean support in APRV is the “drop and 
stretch method.” Increased P high and increased T high improves 
oxygenation. Manipulation of P low and T low regulates end-expiratory lung 
volume. 
 
i. Decrease P high in 2– to 3–cm H2O increments while simultaneously lengthening T high 
in 0.5- to 2-second increments.1 
ii. Decrease P high until it meets P low.  
iii. P high is typically 14 to 16 cm H2O or less, and T high is approximately 12 to 15 
seconds.1 
 
c. Add pressure support as needed to augment spontaneous breathing efforts. The time 
interval between changes is patient dependent. 
 
Rationale: Too long a time interval lengthens stay in the intensive care unit; 
too short a time interval promotes alveolar collapse. 
 
9. Remove gloves and perform hand hygiene. 
10. Document the procedure in the patient’s record. 
 
MONITORING AND CARE 
1. Monitor the patient’s hemodynamic status.  
2. Report any signs of increase in MAP. 
3. Continuously monitor the patient’s peripheral oxygen saturation (SpO2). 
4. Assess the patient’s exhaled minute volume. 
5. Assess the patient’s end-tidal carbon dioxide (ETCO2) level. 
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6. Monitor the patient’s ABG values as needed. 
7. Assess the patient’s overall level of comfort. 
8. To minimize lung derecruitment, consider using a closed suction system to minimize the 
number of times the patient is disconnected from the ventilator. 
9. Observe the patient for signs or symptoms of pain. If pain is suspected, report it to the 
authorized practitioner. 
 
EXPECTED OUTCOMES 
• Improved oxygenation 
• Improved ventilation 
• Improved patient comfort 
• Lung recruitment 
• Minimal ventilator-induced lung injury 
• Liberation from mechanical ventilation 
 
UNEXPECTED OUTCOMES 
• Lung overdistention 
• Worsening oxygenation 
• Worsening ventilation 
• Increase in lung infiltrates 
 
DOCUMENTATION 
• P high 
• P low 
• T high 
• T low 
• FIO2 
• Minute volume 
• Spontaneously breathing at a reasonable rate (e.g., 10 to 25 breaths/min) 
• Work of breathing 
• Spontaneous exhaled volume 
• MAP 
• SpO2 
• ETCO2  
• Patient’s tolerance of procedure 
• Education 
• Unexpected outcomes and related interventions 
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Elsevier Skills Levels of Evidence 
• Level I - Systematic review of all relevant randomized controlled trials 
• Level II - At least one well-designed randomized controlled trial 
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• Level VII - Authority opinion or expert committee reports 
 
Supplies 
• Gloves 
• Mechanical ventilator with APRV mode of ventilation 
• ETCO2 monitor (optional) 
• Pulse oximeter 
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